Cargando…

Duality of P2X7 Receptor in Amyotrophic Lateral Sclerosis

Detalles Bibliográficos
Autores principales:	Volonté, Cinzia, Amadio, Susanna, Liguori, Francesco, Fabbrizio, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394054/ https://www.ncbi.nlm.nih.gov/pubmed/32792962 http://dx.doi.org/10.3389/fphar.2020.01148

Ejemplares similares

Where and Why Modeling Amyotrophic Lateral Sclerosis
por: Liguori, Francesco, et al.
Publicado: (2021)

P2X7 Receptor Activation Modulates Autophagy in SOD1-G93A Mouse Microglia
por: Fabbrizio, Paola, et al.
Publicado: (2017)

Amyotrophic lateral sclerosis disease burden: doing better at getting better
por: Volonté, Cinzia, et al.
Publicado: (2022)

Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis
por: Amadio, Susanna, et al.
Publicado: (2017)

Histaminergic transmission slows progression of amyotrophic lateral sclerosis
por: Apolloni, Savina, et al.
Publicado: (2019)

P2X7 activation enhances skeletal muscle metabolism and regeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis
por: Fabbrizio, Paola, et al.
Publicado: (2019)

Histamine Regulates the Inflammatory Profile of SOD1-G93A Microglia and the Histaminergic System Is Dysregulated in Amyotrophic Lateral Sclerosis
por: Apolloni, Savina, et al.
Publicado: (2017)

Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis
por: Apolloni, Savina, et al.
Publicado: (2014)

P2X7 Receptor Agonist 2′(3′)-O-(4-Benzoylbenzoyl)ATP Differently Modulates Cell Viability and Corticostriatal Synaptic Transmission in Experimental Models of Huntington’s Disease
por: Martire, Alberto, et al.
Publicado: (2021)

Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression
por: Apolloni, Savina, et al.
Publicado: (2016)

Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors
por: Sebastião, Ana M., et al.
Publicado: (2018)

Stimulation of P2X7 Enhances Whole Body Energy Metabolism in Mice
por: Giacovazzo, Giacomo, et al.
Publicado: (2019)

P2X7 receptor antagonism in amyotrophic lateral sclerosis
por: Sluyter, Ronald, et al.
Publicado: (2017)

Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model
por: Apolloni, Savina, et al.
Publicado: (2021)

P2X7 Receptor Antagonism as a Potential Therapy in Amyotrophic Lateral Sclerosis
por: Ruiz-Ruiz, Cristina, et al.
Publicado: (2020)

Mapping P2X and P2Y receptor proteins in striatum and substantia nigra: An immunohistological study
por: Amadio, Susanna, et al.
Publicado: (2007)

Histamine Is an Inducer of the Heat Shock Response in SOD1-G93A Models of ALS
por: Apolloni, Savina, et al.
Publicado: (2019)

Creatine Kinase and Progression Rate in Amyotrophic Lateral Sclerosis
por: Ceccanti, Marco, et al.
Publicado: (2020)

Repurposing Histaminergic Drugs in Multiple Sclerosis
por: Amadio, Susanna, et al.
Publicado: (2022)

Herbal medicine for amyotrophic lateral sclerosis: A systematic review and meta-analysis
por: Song, Yuebo, et al.
Publicado: (2022)

Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis
por: Parrella, Edoardo, et al.
Publicado: (2022)

P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance
por: Coccurello, Roberto, et al.
Publicado: (2020)

New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022
por: Jiang, JingSi, et al.
Publicado: (2022)

P2Y(12) Receptor on the Verge of a Neuroinflammatory Breakdown
por: Amadio, Susanna, et al.
Publicado: (2014)

Extracellular ATP and the P2X(7 )receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis
por: Gandelman, Mandi, et al.
Publicado: (2010)

The P2X7 Receptor-Interleukin-1 Liaison
por: Giuliani, Anna Lisa, et al.
Publicado: (2017)

DnaJC7 in Amyotrophic Lateral Sclerosis
por: Dilliott, Allison A., et al.
Publicado: (2022)

The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
por: Savio, Luiz E. B., et al.
Publicado: (2018)

P2Y(1 )receptor switches to neurons from glia in juvenile versus neonatal rat cerebellar cortex
por: Amadio, Susanna, et al.
Publicado: (2007)

Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1(G93A) mice
por: Scaricamazza, Silvia, et al.
Publicado: (2022)

The Fragile X Protein Family in Amyotrophic Lateral Sclerosis
por: Mueller, Sarah, et al.
Publicado: (2023)

Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral Sclerosis
por: Bouscary, Alexandra, et al.
Publicado: (2019)

CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis
por: Trolese, Maria Chiara, et al.
Publicado: (2020)

Amyotrophic Lateral Sclerosis and Multiple Sclerosis Overlap: A Case Report
por: Trojsi, Francesca, et al.
Publicado: (2012)

Interaction of Purinergic P2X4 and P2X7 Receptor Subunits
por: Schneider, Markus, et al.
Publicado: (2017)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Retromer dysfunction in amyotrophic lateral sclerosis
por: Pérez-Torres, Eduardo J., et al.
Publicado: (2022)

Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation
por: Parisi, C, et al.
Publicado: (2013)

X-ray phase contrast tomography for the investigation of amyotrophic lateral sclerosis
por: Begani Provinciali, Ginevra, et al.
Publicado: (2020)

The Cortical Signature of Amyotrophic Lateral Sclerosis
por: Agosta, Federica, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lcqlvvtr0k29qnivro0qr1l0fk